Overview of Global Diagnostics Partnering 2010-2016


Published on : Apr 12, 2016

ALBANY, New York, April 11, 2016 – Marketresearchhub.com A new market research report, titled “Global Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts,” featured on marketresearchhub.com analyzes the diagnostic partnering agreements entered into by the world’s leading companies. The report covers diagnostic contract documents, agreement terms, agreement structures, top diagnostic deals by value, and the most active diagnostic dealmakers. 

The report contains detailed information about the latest diagnostic agreements announced in the healthcare sector, including the fields of imaging, CT, endoscope, companion diagnostics, molecular and nuclear, MRI, ultrasound, X-ray, PET, SPECT, angiography, theranostics, prognostics, molecular diagnostics, fluoroscopy, and mammography.

A detailed analysis of why and how companies enter diagnostics partnering deals has been presented in the report. The latest diagnostics agreements announced in the life sciences field are given. A comprehensive review of the diagnostic deal trends, top deal values, key players, and financial data has been presented along with an understanding of why, how, and under what terms the companies are entering into diagnostics partnering deals. The deal term values for diagnostic deals, listed by headline value, royalties, upfront payments, and milestone payments, are given, allowing readers to analyze and benchmark the financial value of deals. 

The reader gets an idea of who is leading or succeeding in dealmaking from the report, as it contains details about the diagnostics dealmaker companies. Over 3,600 online deal records of diagnostic deals disclosed by the deal parties have been included by company name in alphabetical order. The deal type, technology type, stage of development, and therapy focus have also been provided in the report. Each deal record links to an online version of the deal, via a weblink. 

Contract documents have been included if available. An in-depth understanding of the diagnostic deal trends since 2010 has been provided in the report. Milestone and royalty data is accessible through this report. Analysis of the structure of diagnostics agreements with numerous case studies has been given in the report. Detailed access to actual diagnostics agreements entered into by biopharma companies is also made possible with the help of the report. 

The study analyzes the deal trends, players, financials, and forecasts so as to provide a reader with a comprehensive study of the diagnostic trends and structure of deals that have been entered into by leading companies across the globe. Trends in diagnostics dealmaking since 2010 in the biopharma industry have been studied. 

The report answers important questions such as the rights granted and optioned in deals, what is actually granted by the agreement to the partner company, the exclusivities that have been granted, the means of resolving disputes, the conditions under which the deal can be terminated, and which jurisdiction the company insists upon for the agreement of the law. 

Click here to get more info with TOC in a PDF Format: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=686335

About MarketResearchHub

MarketResearchHub is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

marketresearchhub’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top